Logos Global Management »

Replimune Group shares owned by Logos Global Management

Quarter-by-quarter ownership of Replimune Group (REPL) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Replimune Group

Tip: Access up to 7 years of quarterly data

All positions including Replimune Group held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Replimune Group by Logos Global Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $28M 2.5M 11.07

More positions owned by Logos Global Management

Erasca (ERAS)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Ideaya Biosciences (IDYA)
Biontech Se Sponsored Ads (BNTX)
Vera Therapeutics Cl A (VERA)
Tango Therapeutics (TNGX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Dyne Therapeutics (DYN)
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Logos Global Management

Top funds holding Replimune Group

Baker Bros. Advisors
BlackRock
T. Rowe Price Associates
Rtw Investments
Ridgeback Capital Investments
Goldman Sachs Group
Suvretta Capital Management
Boxer Capital Management
Caption Management
State Street Corporation
Vanguard Capital Management
Fcpm Iii Services B.v.
Jane Street
AQR Capital Management
Logos Global Management

View all funds holding Replimune Group